InvestorsHub Logo
Followers 467
Posts 26913
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 6278

Saturday, 06/29/2013 12:59:39 PM

Saturday, June 29, 2013 12:59:39 PM

Post# of 6485
4:38PM Insmed to report top-line results from Phase 3 clinical trial of ARIKACE to treat pseudomonas aeruginosa in cystic fibrosis on Monday, July 1 (INSM) 11.96 +0.22 : Co announced that it will report top-line results from its European and Canadian Phase 3 study of ARIKACE (liposomal amikacin for inhalation) to treat cystic fibrosis patients with Pseudomonas aeruginosa lung infections on Monday, July 1, 2013 at 7:00 a.m. Eastern time. Insmed management will hold a conference call to discuss the results and answer questions on Monday, July 1, 2013 beginning at 8:00 a.m. Eastern time.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News